ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 139 filers reported holding ARRAY BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is 3.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,443,000 | -34.3% | 172,370 | -29.8% | 0.02% | -42.3% |
| Q1 2017 | $2,195,000 | +1951.4% | 245,563 | +1453.2% | 0.03% | +2500.0% |
| Q3 2016 | $107,000 | -71.2% | 15,810 | -84.9% | 0.00% | -75.0% |
| Q2 2016 | $372,000 | -17.3% | 104,388 | -2.2% | 0.00% | -20.0% |
| Q4 2015 | $450,000 | -53.0% | 106,714 | -60.2% | 0.01% | -66.7% |
| Q3 2014 | $958,000 | -43.3% | 268,332 | -27.5% | 0.02% | -42.3% |
| Q2 2014 | $1,689,000 | +16.8% | 370,284 | +20.4% | 0.03% | +8.3% |
| Q1 2014 | $1,446,000 | +21.9% | 307,577 | +29.9% | 0.02% | +33.3% |
| Q4 2013 | $1,186,000 | +400.4% | 236,821 | +522.1% | 0.02% | +260.0% |
| Q3 2013 | $237,000 | +144.3% | 38,071 | +78.3% | 0.01% | +150.0% |
| Q2 2013 | $97,000 | – | 21,348 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |